Choosing Between Oral JAK Inhibitors in Atopic Dermatitis

Opinion
Video

Ruth Ann Vleugels, MD, MPH, MBA, provides insights on factors that inform JAK inhibitor treatment selection for patients with atopic dermatitis.

Video content above is prompted by the following questions:

  • How do you choose between different JAK inhibitors? What role do efficacy and safety data play in your selection?
  • What are important considerations when choosing a JAK inhibitor in specific patient populations (e.g., older adults ≥65 yr)?
Recent Videos
Wendy Wright, DNP, an expert on fibromyalgia
A panel of 3 experts on atopic dermatitis
A panel of 3 experts on atopic dermatitis
1 KOL is featured in this series.
A panel of 3 experts on atopic dermatitis
A panel of 3 experts on atopic dermatitis
1 KOL is featured in this series.
Dennis M. Marcus, MD , an expert on neovascular AMD
A panel of 3 experts on atopic dermatitis
A panel of 3 experts on atopic dermatitis
© 2024 MJH Life Sciences

All rights reserved.